piperidines has been researched along with Polycystic-Kidney--Autosomal-Dominant* in 2 studies
2 other study(ies) available for piperidines and Polycystic-Kidney--Autosomal-Dominant
Article | Year |
---|---|
Renal expression of JAK2 is high in polycystic kidney disease and its inhibition reduces cystogenesis.
Autosomal dominant polycystic kidney disease (ADPKD) is the most common renal genetic disorder, however it still lacks a cure. The discovery of new therapies heavily depends on understanding key signalling pathways that lead to ADPKD. The JAnus Kinase and Signal Transducers and Activators of Transcription (JAK/STAT) pathway is aberrantly activated and contributes to ADPKD pathogenesis via enhancing epithelial proliferation. Yet the mechanisms underlying the upregulation of JAK/STAT activity in this disease context is completely unknown. Here, we investigate the role of JAK2 in ADPKD using a murine model of ADPKD (Pkd1 Topics: Animals; Cell Line; Cell Proliferation; Curcumin; Disease Models, Animal; Epithelial Cells; Humans; Janus Kinase 2; Kidney; Mice; Phosphorylation; Piperidines; Polycystic Kidney, Autosomal Dominant; Pyrimidines; Pyrroles; TRPP Cation Channels; Up-Regulation | 2019 |
Activation of P-TEFb by cAMP-PKA signaling in autosomal dominant polycystic kidney disease.
Positive transcription elongation factor b (P-TEFb) functions as a central regulator of transcription elongation. Activation of P-TEFb occurs through its dissociation from the transcriptionally inactive P-TEFb/HEXIM1/7SK snRNP complex. However, the mechanisms of signal-regulated P-TEFb activation and its roles in human diseases remain largely unknown. Here, we demonstrate that cAMP-PKA signaling disrupts the inactive P-TEFb/HEXIM1/7SK snRNP complex by PKA-mediated phosphorylation of HEXIM1 at serine-158. The cAMP pathway plays central roles in the development of autosomal dominant polycystic kidney disease (ADPKD), and we show that P-TEFb is hyperactivated in mouse and human ADPKD kidneys. Genetic activation of P-TEFb promotes cyst formation in a zebrafish ADPKD model, while pharmacological inhibition of P-TEFb attenuates cyst development by suppressing the pathological gene expression program in ADPKD mice. Our study therefore elucidates a mechanism by which P-TEFb activation by cAMP-PKA signaling promotes cystogenesis in ADPKD. Topics: Animals; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cysts; Disease Models, Animal; Flavonoids; Humans; Kidney; Mice; Mice, Knockout; Phosphorylation; Piperidines; Polycystic Kidney, Autosomal Dominant; Positive Transcriptional Elongation Factor B; Protein Binding; Ribonucleoproteins, Small Nuclear; RNA-Binding Proteins; Signal Transduction; Transcription Factors; TRPP Cation Channels; Zebrafish | 2019 |